Xueyao Wang

机构：Shandong University, Guilin Medical University, Beijing University of Chinese Medicine, Karolinska Institutet, Chengdu Institute of Biology · ORCID：0009-0009-9386-0088

发表论文 201 篇 · 总被引 2494 次 · h-index 27

代表论文

• MambaTS: Improved selective state space models for long-term time series forecasting (2026 · Pattern Recognition · 被引 12)
• Multifunctional hydrogels: Therapeutic strategies and advances in inflammation (2025 · European Polymer Journal · 被引 11)
• Prognostic value of radiological and pathological complete response following immune-based conversion therapy in patients with unresectable hepatocellular carcinoma (GUIDANCE004) (2025 · JHEP Reports · 被引 7)
• Survival benefit of hepatectomy after complete or partial response to conversion therapy in unresectable hepatocellular carcinoma (GUIDANCE003): a multi-center study (2025 · Liver Cancer · 被引 6)
• Erratum: Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages (2025 · Hepatology · 被引 4)
• Ketogenic diet impairs NK cell cytotoxic function in colorectal cancer liver metastasis by inducing ferroptosis via suppression of the p62-Keap1-Nrf2 pathway (2025 · Redox Biology · 被引 3)